Xvivo Perfusion AB (XVIVO):企業の財務・戦略的SWOT分析

◆英語タイトル:Xvivo Perfusion AB (XVIVO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14427
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Xvivo Perfusion AB (Xvivo), a subsidiary of Bure Equity AB is a medical technology company that provides organ transplantation solutions. The company develops organ preservation products such as perfadex and silicone tubing sets and normothermic perfusion products. It offers normothermic perfusion products such as STEEN solutions, XVIVO organ chambers, XVIVO lung cannula sets and XPS-XVIVO perfusion systems, among others. Xvivo develops its products based on ex vivo lung perfusion technology. The company markets its products in Italy, Sweden, Turkey, Israel, India, Japan, the US and Brazil, among others. Xvivo is headquartered in Gothenburg, Sweden.

Xvivo Perfusion AB Key Recent Developments

Feb 08,2019: XVIVO Perfusion: Report on operations 2018
Dec 07,2018: Professor Stig Steen’s heart preservation technology required for successful transplantation from pigs to baboons
Oct 26,2018: XVIVO Perfusion: Interim report January – September 2018
Jul 20,2018: Xvivo Perfusion: interim report january-june 2018
Apr 26,2018: XVIVO Perfusion: Interim Report January – March 2018

This comprehensive SWOT profile of Xvivo Perfusion AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Xvivo Perfusion AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Xvivo Perfusion AB – Key Information
Xvivo Perfusion AB – Overview
Xvivo Perfusion AB – Key Employees
Xvivo Perfusion AB – Key Employee Biographies
Xvivo Perfusion AB – Key Operational Heads
Xvivo Perfusion AB – Major Products and Services
Xvivo Perfusion AB – History
Xvivo Perfusion AB – Company Statement
Xvivo Perfusion AB – Locations And Subsidiaries
Xvivo Perfusion AB – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Xvivo Perfusion AB – Business Description
Xvivo Perfusion AB – Corporate Strategy
Xvivo Perfusion AB – SWOT Analysis
SWOT Analysis – Overview
Xvivo Perfusion AB – Strengths
Xvivo Perfusion AB – Weaknesses
Xvivo Perfusion AB – Opportunities
Xvivo Perfusion AB – Threats
Xvivo Perfusion AB – Key Competitors

Section 3 – Company Financial Performance Charts

Xvivo Perfusion AB – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Xvivo Perfusion AB, Key Information
Xvivo Perfusion AB, Key Ratios
Xvivo Perfusion AB, Share Data
Xvivo Perfusion AB, Major Products and Services
Xvivo Perfusion AB, History
Xvivo Perfusion AB, Key Employees
Xvivo Perfusion AB, Key Employee Biographies
Xvivo Perfusion AB, Key Operational Heads
Xvivo Perfusion AB, Other Locations
Xvivo Perfusion AB, Subsidiaries
Xvivo Perfusion AB, Key Manufacturing facilities
Xvivo Perfusion AB, Key Competitors
Xvivo Perfusion AB, SWOT Analysis
Xvivo Perfusion AB, Ratios based on current share price
Xvivo Perfusion AB, Annual Ratios
Xvivo Perfusion AB, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Xvivo Perfusion AB, Performance Chart
Xvivo Perfusion AB, Ratio Charts

★海外企業調査レポート[Xvivo Perfusion AB (XVIVO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Emera (Caribbean) Inc.:企業の戦略的SWOT分析
    Emera (Caribbean) Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Viettel Group
    Viettel Group - Strategy, SWOT and Corporate Finance Report Summary Viettel Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • McWane Inc:企業の戦略的SWOT分析
    McWane Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • EBSCO Industries Inc.:企業の戦略・SWOT・財務分析
    EBSCO Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary EBSCO Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Shiseido Company, Limited:企業の戦略・SWOT・財務情報
    Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Datang International Power Generation Co Ltd (991):企業の財務・戦略的SWOT分析
    Datang International Power Generation Co Ltd (991) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Gindalbie Metals Ltd:企業の戦略・SWOT・財務情報
    Gindalbie Metals Ltd - Strategy, SWOT and Corporate Finance Report Summary Gindalbie Metals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Esab Holdings Ltd:企業の戦略・SWOT・財務分析
    Esab Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Esab Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Biovotion AG:医療機器:M&Aディール及び事業提携情報
    Summary Biovotion AG (Biovotion) is a medical device company that offers healthcare monitoring solutions. The company offers Ecosystem, Everion and Augment app. Its Ecosystem is a wearable sensor monitor that consists of data collection, analytics, storage in the cloud and visualization tools used i …
  • SQI Diagnostics Inc (SQD):企業の製品パイプライン分析2018
    Summary SQI Diagnostics Inc (SQI Diagnostics) is a diagnostic company that offers in vitro diagnostic and pharmaceutical research products. The company’s products comprise sqidworks, sqidlite and sqid-X. Its sqidworks system is used in labs. SQI Diagnostic’s sqidlite is a practical benchtop system. …
  • Laboratoires Thea SA:企業の戦略的SWOT分析
    Laboratoires Thea SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Tonix Pharmaceuticals Holding Corp (TNXP):企業の財務・戦略的SWOT分析
    Summary Tonix Pharmaceuticals Holding Corp (Tonix) is a developer of pharmaceutical products to address public health challenges. The company offers pharmaceutical products and treatments for disorders of the central nervous system including fibromyalgia, post traumatic stress disorder and episodic …
  • Neuland Laboratories Ltd (NEULANDLAB)-製薬・医療分野:企業M&A・提携分析
    Summary Neuland Laboratories Ltd (Neuland Lab), a subsidiary of Neuland Health Sciences Pvt Ltd is an API manufacturing service provider that manufactures active pharmaceutical ingredients, advanced intermediates; and offers chemistry related services. The company offers APIs in various therapeutic …
  • ACWA Power Barka SAOG (APBS):企業の財務・戦略的SWOT分析
    ACWA Power Barka SAOG (APBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sanochemia Pharmazeutika AG (SAC):企業の財務・戦略的SWOT分析
    Sanochemia Pharmazeutika AG (SAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Wartsila Corp (WRT1V):電力:M&Aディール及び事業提携情報
    Summary Wartsila Corp (Wartsila) is a mechanical or industrial engineering company. It offers smart technologies and complete lifecycle solutions. Through sustainable innovation, total efficiency, and data analytics, the company harnesses the environmental and economic performance of the vessels and …
  • Dynegy Inc:企業の発電所・SWOT分析2018
    Dynegy Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • Airasia Group Berhad:企業の戦略・SWOT・財務分析
    Airasia Group Berhad - Strategy, SWOT and Corporate Finance Report Summary Airasia Group Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • InFlectis BioScience:製薬・医療:M&Aディール及び事業提携情報
    Summary InFlectis BioScience (InFlectis) is a drug discovery company that identifies and develops small molecule drugs that target the unfolded protein response to treat misfolding protein disorders such as age-related and neurodegenerative diseases. The company’s pipeline products include IFB-088, …
  • Companhia Energetica de Sao Paulo (CESP6):電力:M&Aディール及び事業提携情報
    Summary Companhia Energetica de Sao Paulo (CESP) is a state-owned integrated electric utility. It plans, constructs, and operates electric energy generation and commercialization systems. The company produces energy using hydro source. CESP owns power plants at Rio Paran, Rio Paraibuna, and Rio Jagu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆